Visual acuities at baseline and at follow-up for study eyes with DME and RVO
| Mean logMAR VA±SD (Snellen conversion) | DME | RVO | ||
| SRF | Non-SRF | SRF | Non-SRF | |
| Baseline | 0.648±0.354 (20/90) | 0.579±0.349 (20/80) | 0.891±0.572 (20/160) | 0.838±0.630 (20/140) |
| 1 month | 0.597±0.315 (20/80) | 0.595±0.395 (20/80) | 0.844±0.520 (20/140) | 0.704±0.556 (20/100) |
| 3 months | 0.584±0.359 (20/80) | 0.604±0.445 (20/80) | 0.643±0.420 (20/90) | 0.658±0.500 (20/90) |
| 6 months | 0.560±0.391 (20/70) | 0.593±0.454 (20/80) | 0.533±0.287 (20/70) | 0.590±0.491 (20/80) |
| 12 months | 0.500±0.399 (20/60) | 0.580±0.476 (20/80) | 0.546±0.430 (20/70) | 0.614±0.498 (20/80) |
| 24 months | 0.412±0.284 (20/50) | 0.607±0.571 (20/80) | 0.813±0.791 (20/130) | 0.681±0.588 (20/100) |
DME, diabetic macular oedema; logMAR, logarithm of the minimum angle of resolution; RVO, retinal vein occlusion; SRF, subretinal fluid; VA, visual acuity.